This week, Mark and Margaret speak with Dr. Yulun Wang, Chairman & Chief Executive Officer of InTouch Health. Dr. Wang launched his career at the intersection of healthcare and technology with the founding of Computer Motion, Inc. and the invention of AESOP, the first FDA-cleared surgical robot. Under his leadership, Computer Motion went public in 1997 and later merged with Intuitive Surgical to forge the multi-billion dollar surgical robotics industry. In 2002, Dr. Wang founded InTouch Health, which has been recognized as one of the fastest growing healthcare and technology companies in the world.
The Cutting Edge Career: Dr. Yulun Wang on Surgical Robotics and InTouch Health

Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
This week, Mark and Margaret speak with Dr. Yulun Wang, Chairman & Chief Executive Officer of InTouch Health. Dr. Wang launched his career at the intersection of healthcare and technology with the founding of Computer Motion, Inc. and the invention of AESOP, the first FDA-cleared surgical robot. Under his leadership, Computer Motion went public in 1997 and later merged with Intuitive Surgical to forge the multi-billion dollar surgical robotics industry. In 2002, Dr. Wang founded InTouch Health, which has been recognized as one of the fastest growing healthcare and technology companies in the world.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
IgG4-RD Case Conversations: Diagnosing Pancreaticobiliary Manifestations and Ruling Out Malignancy
IgG4-RD Case Conversations: IgG4-related Autoimmune Pancreatitis and Cholangitis
Updates From the 7th World Symposium Task Force
Spinal Muscular Atrophy: Optimizing the Management of Adults in the Era of Disease-Modifying Therapies
TIME OUT: A Case-Based Deep Dive into the Challenges of ARIA Management
New Horizons: Unraveling Novel Therapies for Enhanced Cardiovascular Outcomes in Patients With Heart Failure
Partnering with Patients: Building Effective Communication and Support in HF Care
The Importance of PD-L1 Testing: Shaping the Future of Treatment in ESCC
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?